BesaGov

Contract W911QY13C0056

Dynport Vaccine Company Llc · Department Of Defense · May 9, 2013

Cost Plus Fixed FeeFull & Open CompetitionNAICS 541711

Dynport Vaccine Company Llc was awarded a federal contract by Department Of Defense (Department Of The Army) on May 9, 2013 for $117.63 million of work in research and development in biotechnology. Performance is in Frederick, MD. It was awarded under full and open competition. The contract has been modified 80 times since the base award It uses cost-plus contract pricing. The most recent modification was on September 12, 2025. If all options are exercised, the contract could reach $258.06 million.

Obligated to date
$117.63M
$117,632,941
Current value
$257.42M
Potential value
$258.06M
if all options exercised
Modifications
80
Latest September 12, 2025

Contract details

PIID
W911QY13C0056
Award type
Definitive Contract
Pricing
Cost Plus Fixed Fee
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541711 · Research And Development In Biotechnology
Product / service
Drugs And Biologicals
Place of performance
Frederick, MD
First action
May 9, 2013
Latest action
September 12, 2025

Description

TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.

Modification timeline

  • September 12, 2025
    Mod P00080
    $-316.9K
  • July 25, 2025
    Mod P00079
    EXTEND DEADLINE FOR TERMINATION SETTLEMENT PROPOSAL SUBMISSION DATE TO 12 MARCH 2026 UNDER TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.
    $0
  • March 13, 2024
    Mod P00078
    EXTEND DEADLINE FOR TERMINATION SETTLEMENT PROPOSAL SUBMISSION DATE TO 14 MARCH 2024 UNDER TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.
    $0
  • March 31, 2023
    Mod P00077
    EXTEND DEADLINE FOR TERMINATION SETTLEMENT PROPOSAL SUBMISSION DATE TO 14 MARCH 2024 UNDER TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS
    $0
  • March 9, 2022
    Mod P00076
    ADMIN ACTION TO EXTEND TERMINATION SETTLEMENT PROPOSAL DEADLINE FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
    $0
  • March 4, 2021
    Mod P00075
    FDA LICENSURE OF A BIOSCAVENGER PROPHYLA - ADMIN MODIFICATION
    $0
  • August 8, 2019
    Mod P00074
    FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
    $-7.70M
  • August 5, 2019
    Mod P00073
    FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
    $0
  • May 24, 2019
    Mod P00072
    FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
    $-5.47M
  • April 4, 2019
    Mod P00071
    FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
    $11.19M
Sign up free to see all 81 modifications

Similar contracts

RecipientAgencyDateObligated
Bluehalo, LlcDepartment Of DefenseNovember 4, 2025$0
Bluehalo, LlcDepartment Of DefenseNovember 4, 2025$0
Bluehalo, LlcDepartment Of DefenseNovember 4, 2025$3.00M
Inbios International IncDepartment Of DefenseSeptember 22, 2025$25.66M
Westat, Inc.Department Of DefenseAugust 28, 2025$22.21M
Deka Integrated Solutions CorpDepartment Of DefenseAugust 25, 2025$8.85M

Top contractors in NAICS 541711

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Alliance For Energy Innovation, Llc2$10.68B
2Emergent Product Development Gaithersburg Inc.7$1.63B
3Janssen Pharmaceuticals, Inc.2$1.05B
4Regeneron Pharmaceuticals Inc4$1.01B
5Siga Technologies, Inc.3$560.59M
6Battelle National Biodefense Institute, Llc106$469.31M
7Glaxosmithkline, Llc6$321.65M
8Merck Sharp & Dohme Llc3$309.72M
9Sri International130$258.61M
10American Type Culture Collection7$243.18M

Explore related

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract W911QY13C0056?

Contract W911QY13C0056 is a federal contract awarded to Dynport Vaccine Company Llc by Department Of Defense on May 9, 2013 for $117.63 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 80 times since the base award.

Who won contract W911QY13C0056?

Dynport Vaccine Company Llc won contract W911QY13C0056 from Department Of Defense.

How much is contract W911QY13C0056 worth?

Contract W911QY13C0056 has obligated $117.63 million to date, with a total potential value of $258.06 million if all options are exercised.